Resumen: Teva recibe la autorización de comercialización de la UE para Seffalair® Spiromax® y BroPair® Spiromax® (xinafoato de salmeterol/propionato de fluticasona) | Business Wire
Teva Pharmaceutical Industries' quest to acquire Mylan NV could wind up in a Dutch court - Pittsburgh Business Times
Financial data Teva Pharm.: Equity Research, Quotes | Valuespectrum.com
Teva Pharmaceutical Finance Netherl. IV BV AMSTERDAM - Oozo.nl
Dilek Dogan - Sr.Director, Head of CNS Europe - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceuticals Europe - Home | Facebook
REEF & TEVA Teva HURRICANE DRIFT - Sandalias hombre dark grey - Private Sport Shop